Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART).
Williams MC, Kwiecinski J, Doris M, McElhinney P, D'Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah ASV, Mills NL, Pawade T, Wang C, Weir McCall J, Bonnici-Mallia M, Murrills C, Roditi G, van Beek EJR, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR, Dey D. · 2020
Read Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). by Williams MC, Kwiecinski J, Doris M, McElhinney P, D'Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah ASV, Mills NL, Pawade T, Wang C, Weir McCall J, Bonnici-Mallia M, Murrills C, Roditi G, van Beek EJR, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR, Dey D. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7195857.txt.
Introduction
Williams and co-authors test whether a soft, fatty type of plaque in heart arteries predicts heart attacks. Their study appeared in Circulation. It draws on the SCOT-HEART trial of CT scans in patients with stable chest pain. Usual risk tools rely on scores, calcium levels, or artery narrowing. The team asked whether plaque character does better.
They measured low-attenuation noncalcified plaque as a share of vessel volume. This soft plaque is the kind most likely to rupture. Patients carrying more of it faced higher risk of later heart attack. The measure beat the standard tools in their analysis. Calcium scores, by contrast, mark stable hardened plaque. The findings argue for reading scans by plaque type, not just blockages.
Catalog record
| CREATOR | Williams MC, Kwiecinski J, Doris M, McElhinney P, D'Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah ASV, Mills NL, Pawade T, Wang C, Weir McCall J, Bonnici-Mallia M, Murrills C, Roditi G, van Beek EJR, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR, Dey D. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction By Michelle C. Williams, Jacek Kwiecinski, Mhairi Doris, Priscilla McElhinney, Michelle S. D’Souza, Sebastien Cadet, Philip D. Adamson, Alastair J. Moss, Shirjel Alam, Amanda Hunter, Anoop S.V. Shah, Nicholas L. Mills Published in: Circulation DOI: 10.1161/CIRCULATIONAHA.119.044720 ABSTRACT BACKGROUND: The future risk of myocardial infarction is commonly assessed using cardiovascular risk scores, coronary artery calcium score, or coronary artery stenosis severity. We assessed whether noncalcified low-attenuation plaque burden on coronary CT angiography (CCTA) might be a better predictor of the future risk of myocardial infarction. METHODS: In a post hoc analysis of a multicenter randomized controlled trial of CCTA in patients with stable chest pain, we investigated the association between the future risk of fatal or nonfatal myocardial infarction and low-attenuation plaque burden (% plaque to vessel volume), cardiovascular risk score, coronary artery calcium score or obstructive coronary artery stenoses. RESULTS: In 1769 patients (56% male; 58±10 years) followed up for a median 4.7 (interquartile interval, 4.0–5.7) years, low-attenuation plaque burden correlated weakly with cardiovascular risk score (r=0.34; P<0.001), strongly with coronary artery calcium score (r=0.62; P<0.001), and very strongly with the severity of luminal coronary stenosis (area stenosis, r=0.83; P<0.001). Low-attenuation plaque burden (7.5% [4.8–9.2] versus 4.1% [0–6.8]; P<0.001), coronary artery calcium score (336 [62–1064] versus 19 [0–217] Agatston units; P<0.001), and the presence of obstructive coronary artery disease (54% versus 25%; P<0.001) were all higher in the 41 patients who had fatal or nonfatal myocardial infarction. Low-attenuation plaque burden was the strongest predictor of myocardial infarction (adjusted hazard ratio, 1.60 (95% CI, 1.10–2.34) per doubling; P=0.014), irrespective of cardiovascular risk score, coronary artery calcium score, or coronary artery area stenosis. Patients with low-attenuation plaque burden greater than 4% were nearly 5 times more likely to have subsequent myocardial infarction (hazard ratio, 4.65; 95% CI, 2.06–10.5; P<0.001). CONCLUSIONS: In patients presenting with stable chest pain, low-attenuation plaque burden is the strongest predictor of fatal or nonfatal myocardial infarction. These findings challenge the current perception of the supremacy of current classical risk predictors for myocardial infarction, including stenosis severity. REGISTRATION: URL: http://www.clinicaltrials.gov; Unique identifier: NCT01149590. The current clinical paradigm of coronary artery disease is based on cardiovascular risk scores and the presence of obstructive stenoses in the coronary vasculature.1,2 Coronary computed tomography angiography (CCTA) has the ability to visualize both the coronary artery lumen and any surrounding atherosclerotic plaque.3,4 This allows additional assessment of coronary plaque burden and plaque type, both of which may improve our understanding of coronary atherosclerosis and cardiovascular risk prediction.5,6 Coronary artery calcium scoring on noncontrast computed tomography (CT) using the Agatston method7 has been widely used as a surrogate marker of coronary plaque burden, providing powerful cardiovascular risk prediction8,9 that is additive to traditional cardiovascular risk scores.10,11 However, these macrocalcified plaques are generally considered a more stable form of atherosclerosis and, hence, relatively unlikely to rupture and cause myocardial infarction directly.12 There is considerable interest in quantifying the burden of less stable plaque components that might more directly contribute to events. Histological plaque characteristics that have been associated with plaque rupture and myocardial infarction include inflammation, microcalcification, a thin fibrous cap, and a large lipid-rich necrotic core.13-15 On CCTA, a lipid rich necrotic core can be detected as low-attenuation noncalcified plaque.16 We have recently demonstrated that visually identifying such plaque may be of benefit in predicting the future risk of myocardial infarction.17 However, such qualitative assessments are relatively subjective, time consuming, and nonquantitative. Recent developments now allow the reproducible and semiautomatic quantification of the burden of calcified, noncalcified, and low-attenuation plaque across the coronary arteries on contrast CT angiography.18,19 This study aimed to investigate whether quantification of CCTA-defined low-attenuation plaque improves the prediction of fatal or nonfatal myocardial infarction compared with cardiovascular risk scores, Agatston coronary artery calcium scoring, and the severity of obstructive coronary artery disease in stable patients with chest pain undergoing CCTA. METHODS Study Design The data supporting the findings of this study are available from the corresponding author for checking the reproducibility of the study results. The SCOT-HEART multicenter randomized controlled trial (Scottish Computed Tomography of the HEART) assessed the use of CCTA in patients with suspected angina attributable to coronary artery disease (ClinicalTrials.gov. Unique identifier: NCT01149590).20 The study was approved by the local ethics committee and written informed consent was provided by all participants. The primary results have been published previously.21-23 Patients attending cardiology outpatient clinics were randomized to standard care or standard care plus CT. Of the 4146 trial participants, 2073 were randomized to undergo CT. Of these, 1778 underwent CT and 1769 scans were available and of suitable quality for analysis in this substudy. Cardiovascular risk was calculated using the ASSIGN (Assessing cardiovascular risk using SIGN guidelines) cardiovascular risk score.24 This is a wellvalidated risk score based on the Framingham risk score and has been calibrated to the Scottish population. CT Imaging Participants underwent both noncontrast electrocardiogram-gated CT for calcium scoring and contrast enhanced electrocardiogram-gated CCTA.20 Imaging was performed at one of three sites using either 64- or 320-detector row scanners (Brilliance 64, Philips Medical Systems, Netherlands; Biograph mCT, Siemens, Germany; Aquilion ONE, Toshiba Medical Systems, Japan). Tube current, voltage, and volume of iodinebased contrast were adjusted based on body mass index. Visual Assessment of CT Coronary artery calcium score and coronary artery stenosis assessments were obtained from the SCOT-HEART database. Coronary artery calcium score was assessed using the Agatston scoring method, as described previously.7,20 Coronary artery stenoses were visually assessed on a 15-segment basis by trained observers with excellent inter- and intraobserver variability, as described previously.25 In brief, the luminal area stenosis was here visually classified as normal, nonobstructive (<50% in left main stem or <70% in other segments), and obstructive (≥50% in left main stem or ≥70% in other segments). Obstructive coronary artery disease was defined as the presence of 1 or more major epicardial vessel with an obstructive stenosis. Quantitative Assessment of CT Quantitative assessment of atherosclerotic plaque subtypes was performed using standardized semiautomatic software (Autoplaque, Version 2.5, Cedars-Sinai Medical Center) by 1 of 4 trained observers. Excellent interobserver, intraobserver, and interscan agreement has previously been established for this technique (Spearman r=0.87–0.99).18,26 Quantitative analysis was performed for all patients who had 1 or more segments of nonobstructive or obstructive disease or a coronary artery calcium score greater than 0. For patients with normal coronary arteries, the plaque volumes and burden were set to 0. Coronary artery centerlines were extracted using a semiautomated method. A circular region of interest was placed in the proximal aorta to define the normal reference blood pool attenuation. The proximal and distal aspects of coronary artery segments with atherosclerotic plaque were manually defined. Scan-specific thresholds for plaque constituents were generated, as described previously.27 Vessel lumen, wall, and plaque constituents were automatically identified, with manual adjustment performed as required (Figure 1). Automatic quantification of area stenosis at the narrowest point of the segmented lumen was performed. Plaque volumes (in mm3) were measured for the following plaque subtypes: total plaque, calcified plaque, noncalcified plaque and low-attenuation plaque (defined by an attenuation of <30 Hounsfield units [HU]).19 Plaque burden (as a percentage) was calculated for each of the total plaque, noncalcified plaque, low-attenuation plaque,